Management and Quality Control

Chatammour Henderson Marketing Management Seminar 640 February 25, 2012 Asterand account What is the ultimate stopping point of Asterands forest govern initiative? Asterand clearly did not have an effective smell jibe system in process precedent to accepting its contract with Amgen to supply forgiving tissue samples.Although Asterand is a new provider to the biopharmaceutic and pharmaceutical industry, it forget need to immediately establish quality control methods that will allow them to process orders correctly and go to sleep the final product to the standards and requirements of the procuring caller-up. This will butt against Asterands ability to provide lucid and reliable human-tissue samples that meet the rigorous restrictive standards that the FDA places on all biotechnology and pharmaceutical products.As indicated in the case study, Asterand failed to meet Amgens quality standards on four do with different reasons. Asterands quality control challenges did not begin with Amgen. Asterand also set about challenges with implementing standardized protocols for storage and data array across laboratories and hospitals, organizing and storing samples over long periods, and group meeting the stringent regulatory requirements for clinical testing.It is assertive that Asterand addresses these challenges in order to stay in business and to expand the company. Human-tissue sampling is a new and innovative process that rouse be rejected by its train consumers if it does not have good quality control methods. Asterands ultimate goal of the quality control initiative is to be well received in the quoin human-tissue sample market so that the company can increase sales growth, firm financing, attract investors and ultimately expand its operations.